CamouflagingAttenuated Salmonella by Detachable MetalPolyphenol Nanoshells for Enhanced Bacteria-Based Cancer Immunotherapy

We developed <i>Salmonella typhimurium</i> VNP20009 camouflaged biodegradable metal polyphenol nanoshells for efficiently reducing bacterial virulence and prolonging bacterial in vivo circulation time to increase bacterial tumor enrichment. The four-layer nanoshell-encapsulated VNP20009 (M<sub>4</sub>@V) ensured the safety of treatment by effectively inhibiting bacterial proliferation and significantly reducing the toxicity in vivo. Moreover, the nanoshells significantly enhanced the biocompatibility of VNP20009 to protect it from phagocytosis, resulting in a 4-fold in vivo circulation time and a 1.97-fold increase in peak accumulation at the tumor sites. After the M<sub>4</sub>@V colonized in the tumor microenvironment, physiologically relevant levels of ascorbic acid (AA) triggered the degradation of the nanoshells to restore the proliferation of VNP20009 at the tumor sites. Within 4T1 tumor-bearing mouse models, the AA+M4@V showed remarkable efficacy in suppressing both primary and metastatic tumors and was accompanied by a highly specific immune response.

Publication Details

Journal
Figshare
Published
2025-03-26
DOI
https://doi.org/10.1021/acsmaterialslett.5c00012.s001
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CamouflagingAttenuated Salmonella by Detachable MetalPolyphenol Nanoshells for Enhanced Bacteria-Based Cancer Immunotherapy

Figshare
Cancer Research and Treatments
article

CamouflagingAttenuated Salmonella by Detachable MetalPolyphenol Nanoshells for Enhanced Bacteria-Based Cancer Immunotherapy

article en

Abstract

We developed <i>Salmonella typhimurium</i> VNP20009 camouflaged biodegradable metal polyphenol nanoshells for efficiently reducing bacterial virulence and prolonging bacterial in vivo circulation time to increase bacterial tumor enrichment. The four-layer nanoshell-encapsulated VNP20009 (M<sub>4</sub>@V) ensured the safety of treatment by effectively inhibiting bacterial proliferation and significantly reducing the toxicity in vivo. Moreover, the nanoshells significantly enhanced the biocompatibility of VNP20009 to protect it from phagocytosis, resulting in a 4-fold in vivo circulation time and a 1.97-fold increase in peak accumulation at the tumor sites. After the M<sub>4</sub>@V colonized in the tumor microenvironment, physiologically relevant levels of ascorbic acid (AA) triggered the degradation of the nanoshells to restore the proliferation of VNP20009 at the tumor sites. Within 4T1 tumor-bearing mouse models, the AA+M4@V showed remarkable efficacy in suppressing both primary and metastatic tumors and was accompanied by a highly specific immune response.

Figshare
Good health and well-being
Openalex Percentile: Top 57%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.